Thermo Fisher Scientific Inc: Beat — EPS $6.68, Revenue $12.14B
Earnings BeatQ3 2026 · Pre-market
@trystockwhiz
Did Thermo Fisher Scientific Inc (TMO) beat earnings today?
Yes, Thermo Fisher Scientific Inc (TMO) beat Wall Street analyst expectations for Q3 2026, reporting higher-than-expected EPS and higher-than-expected revenue.
Earnings Per Share+4.37% surprise
$6.68Actual
Expected: $6.40
vs. year ago +15.0%
Total Revenue+1.56% surprise
$12.14BActual
Expected: $11.95B
vs. year ago +9.0%
Released Oct 21 · 6:00 AM ET
Earning Report
| Metric | Q3 2026 | Q3 2025 | YoY Change % |
|---|---|---|---|
| Revenue | $12.14B | $11.12B | +9.0 |
| Revenue detail — reported lines | |||
| └─Life Sciences Solutions | $2.72B | $2.59B | +5.1 |
| └─Analytical Instruments | $2.00B | $1.89B | +5.8 |
| └─Specialty Diagnostics | $1.10B | $1.17B | -6.5 |
| └─Laboratory Products and Biopharma Services | $6.86B | $5.97B | +15.0 |
| Net Income | $1.73B | $1.62B | +6.5 |
| GAAP Basic EPS | $4.65 | $4.28 | +8.9 |
| GAAP Diluted EPS | $4.64 | $4.27 | +9.0 |
| Adjusted EPS | $6.68 | $5.79 | +15.0 |
Business Highlights
- ➤Launched Orbitrap Isora mass spectrometer for isotope ratio analysis.
- ➤Launched EMPAD G2 electron detector for advanced-materials characterization.
- ➤Received U.S. FDA clearance for the EliA CTD 13 Screen autoimmune test.
- ➤Launched Ion 560 Chip with nearly twice prior sequencing capacity.
- ➤Partnered with Mayo Clinic to launch the Precure precision-medicine initiative.
- ➤Opened its first AI-Automation Innovation Center in South Korea.
- ➤Opened a highly automated Kentucky distribution center serving North American customers.
- ➤Completed the previously announced divestiture of its microbiology business.
Management Commentary
Marc N. Casper, chairman and chief executive officer
“We are very pleased to deliver another excellent quarter, with outstanding financial performance on both the top and bottom line. We’re advancing our proven growth strategy, which is resonating strongly with our customers, and our PPI Business System is enabling outstanding execution across the company.”
Marc N. Casper, chairman and chief executive officer
“Looking ahead, we’re well positioned to deliver an excellent 2026 as we continue to drive long-term value creation for all of our stakeholders and build an even brighter future for our company.”